In the heterozygous state, the cystic fibrosis transmembrane conductance regulator (CFTR) exon 11 mutation G551D has been described as "severe," causing pancreatic insufficiency. Two cystic fibrosis (CF) patients homozygous for this mutation showed a mild rather than severe pancreatic phenotype and a variable pulmonary phenotype. (7Med Genet 1996;33:711-713) 
Methods
Cheekbrush DNA for CFTR mutation analysis was collected and prepared according to Richards et al.1 CFTR mutation analysis was performed for 12 mutations (AF508, G551D, G542X, 621 + 1G->T, AI507, 1717-1G-4A, R117H, N1303K, W1282X, R560T, R553X, 3849 + 1Okb C-+T). Genotyping for all CFTR mutations, except for 3849 + lOkb C-+T, which was assessed by restriction enzyme digestion with HphI,' were evaluated by the Multiplex Amplification Refractory Mutation System (ARMS).3 The reaction volumes were modified from the Ferrie protocol to incorporate 20 ,ul of buccal cell DNA into the PCR reaction mixture. DNA from patient 1 was also assessed for 12 mutations by allele specific oligonucleotide analysis (ASO),4 but S549N was screened in addition, and 3849 + 1Okb was excluded.
Case reports CASE 1 This patient was a white female diagnosed with CF at the age of 6, with a history of recurrent pneumonia and no malabsorption or gastrointestinal symptoms. Family history was positive for CF in a maternal cousin. All grandparents were from Ireland, although there was no history of consanguinity. Quantitative pilocarpine iontophoresis at diagnosis showed a sweat chloride value of 107 mEq/l. She was subsequently admitted to hospital two to three times a year for pulmonary exacerbations. She developed steroid dependent reactive airway disease. Her sputum grew mucoid Pseudomonas aeruginosa before the age of 12. By the age of 15, percent predicted forced vital capacity (FVC) and forced expiratory volume in one second (FEV1) were 50%. When pancreatic enzyme supplementation was started at the age of 16 (owing to low vitamin A level), height and weight were at the 50th centile for age. There was no liver disease or diabetes mellitus (DM).
In her mid teens she developed mild haemoptysis and gradually declining pulmonary function with increasing frequency of admission to hospital for pulmonary exacerbations. Chest radiograph and chest computed tomography showed bronchiectasis. By the age of 19 she required night time oxygen supplementation and developed CO2 retention. She died at the age of 20 of progressive respiratory failure. CASE 2 This patient was first diagnosed with CF at the age of 36 with complaints of chronic bronchitis and asthma. Although always short and thin (height and weight at the 5th-lOth centile), he had no malabsorption stools or GI symptoms until the age of 15. At that time, he was admitted to hospital for a transient bowel obstruction which was successfully treated by enema. There was no liver disease or DM. Chronic cough was present from infancy. Although he complained of exertional dyspnoea as a child, asthma was not diagnosed until the age of 17. Treatment included inhaled steroids and bronchodilators. There was no documented pneumonia and no admissions to hospital for respiratory problems. An infertility evaluation at the age of 33 showed azoospermia. His first episode of mild haemoptysis occurred at the age of 34 after a sudden coughing paroxysm. The CXR, which had been previously reported as unremarkable, had changed to a granular nodular pattern with peribronchial thickening. A diagnosis of sarcoidosis was considered, and thoracoscopic biopsy indicated an it tory non-granulomatous process and tis. Because the diagnosis of CF was in the differential diagnosis, a quantiti carpine iontophoresis was perforn showed a sweat chloride of 101 mEq/l grew Staphylococcus aureus and rE mucoid Pseudomonas aeruginosa. Fol first course of intravenous antibioti bronchodilator FVC was 98%, FEV1' forced expiratory flow from 25 to 75 ¶ capacity (FEF25-75) 28%. Vitamin A a els, prothrombin, and partial throml time and 72 hour stool fat collection N mal. Family history was negative for there was no known consanguinity. For the two cases presented, phenotypic similarities include the relatively mild pancreatic (late mnild PI in patient 1 compared to PS in patient 2) and mild intestinal phenotypes (no MI in the newborn period for either, and late meconium ileus equivalent in patient 2) and presentation with mainly respiratory symptoms (although one was mild and the ultiplex other severe). The ages of diagnosis and age at taining PI in patients 1 and 2 are much older than the 0ormal means proposed for AF508/G551D heteroloci. The zygotes6(table 1). The disparity in severity of id pattern respiratory disease of these patients could be
Results
The third related to the absence of mucoid Pseudomonas aeruginosa (an organism known to be associ-Phenotype of CFTR mutation G551D The disparate outcomes of these two patients shows both that severe pancreatic insufficiency is not necessarily a clinical feature of the G551D homozygous genotype, and thai a mild pulmonary phenotype is possible. Pulmonary outcome cannot be predicted by CFTR genotype alone. These findings support the hypothesis that considering the influence of non-CFTR genes and environmental influences will be necessary to understand variability in the CF phenotype.
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